Comparison of a dry powder inhaler (DPI) to a pressurized metered-dose inhaler (pMDI) formulation of extra fine beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide (BDP/FF/GB) in patients with COPD: The TRI-D study.

K. Beeh (Wiesbaden, Germany), P. Kuna (Lodz, Poland), I. Viaud (Parma, Italy), A. Guasconi (Parma, Italy), M. Corradi (Parma, Italy), G. Georges (Parma, Italy)

Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Session: COPD : inhaled corticosteroids, bronchodilators and eosinophils
Session type: E-poster session
Number: 3246
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Beeh (Wiesbaden, Germany), P. Kuna (Lodz, Poland), I. Viaud (Parma, Italy), A. Guasconi (Parma, Italy), M. Corradi (Parma, Italy), G. Georges (Parma, Italy). Comparison of a dry powder inhaler (DPI) to a pressurized metered-dose inhaler (pMDI) formulation of extra fine beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide (BDP/FF/GB) in patients with COPD: The TRI-D study.. 3246

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: